Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference21 articles.
1. Cancer statistics;Jemal;CA Cancer J Clin,2007
2. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial;Reni;Lancet Oncol,2005
3. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297;Berlin;J Clin Oncol,2002
4. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial;Louvet;J Clin Oncol,2005
5. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer;Bramhall;Br J Cancer,2002
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The efficacy and mechanism of proteasome inhibitors in solid tumor treatment;Recent Patents on Anti-Cancer Drug Discovery;2021-12-02
2. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals;Advances in Biological Regulation;2018-08
3. A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas;British Journal of Haematology;2013-08-08
4. Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer;Journal of Surgical Research;2013-06
5. Phytochemicals As Chemosensitizers: From Molecular Mechanism to Clinical Significance;Antioxidants & Redox Signaling;2013-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3